Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Clinical trial NCT00602641 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00602641
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-29
- Primary completion
- 2014-01-18
- Enrollment
- 306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.